| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |